STEVEN C MILLER
Allopathic & Osteopathic Physicians|Internal Medicine PIKESVILLE, MD NPI 1003874355
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MD Astellas Pharma US Inc All categories
General Payments — all program years on this page
$10,307.86
- Category: General Payments
- Program years: PY2018–2024
- Record count: 595
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,050.81 across 88 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,050.81 | 88 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $256.09 | 9 |
| Novo Nordisk AS | $233.12 | 20 |
| GlaxoSmithKline, LLC. | $232.52 | 7 |
| ABBVIE INC. | $221.13 | 5 |
| SANOFI-AVENTIS U.S. LLC | $214.10 | 3 |
| Acerta Pharma LLC | $120.92 | 5 |
| Abbott Laboratories | $100.77 | 5 |
| Amgen Inc. | $91.55 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.59 | 5 |
| Lilly USA, LLC | $84.11 | 5 |
| Merck Sharp & Dohme Corporation | $74.74 | 3 |
| PFIZER INC. | $64.28 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $48.23 | 2 |
| Exact Sciences Corporation | $36.42 | 2 |
| Sumitomo Pharma America, Inc. | $28.95 | 1 |
| Daiichi Sankyo Inc. | $28.83 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.05 | 1 |
| Microtransponder, Inc. | $19.86 | 1 |
| Esperion Therapeutics, Inc. | $18.76 | 1 |
| Medtronic, Inc. | $18.67 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.20 | 1 |
| ITI, Inc. | $15.88 | 1 |
By program year
Records — PY2024 (88)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.